Voronoi Inc is a Korea-based company principally engaged in the research and development of new drug candidates. The Company is principally engaged in the technology transfer of new drug candidates prior to electroclinical clinical trials. The Company is principally engaged in the research and development of kinase inhibitor as well as others. In addition, the Company is also engaged in the building and supply of new drug development platforms based on artificial intelligence (AI) and research results.
More about the company